Search Results - "FISHER, George"

Development and Validation of a Deep Learning CT Signature to Predict Survival and Chemotherapy Benefit in Gastric Cancer: A Multicenter, Retrospective Study by Jiang, Yuming, Jin, Cheng, Yu, Heng, Wu, Jia, Chen, Chuanli, Yuan, Qingyu, Huang, Weicai, Hu, Yanfeng, Xu, Yikai, Zhou, Zhiwei, Fisher, George A., Li, Guoxin, Li, Ruijiang

“…OBJECTIVE:We aimed to develop a deep learning-based signature to predict prognosis and benefit from adjuvant chemotherapy using preoperative computed…”
Get full text

CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer by Dalerba, Piero, Sahoo, Debashis, Paik, Soonmyung, Guo, Xiangqian, Yothers, Greg, Song, Nan, Wilcox-Fogel, Nate, Forgó, Erna, Rajendran, Pradeep S, Miranda, Stephen P, Hisamori, Shigeo, Hutchison, Jacqueline, Kalisky, Tomer, Qian, Dalong, Wolmark, Norman, Fisher, George A, van de Rijn, Matt, Clarke, Michael F

“…CDX2 is expressed in most colon cancers, but approximately 4% do not express this transcription factor. Lack of CDX2 expression marks a subset of cancers with…”
Get full text

Dose-Escalation Study of Single-Fraction Stereotactic Body Radiotherapy for Liver Malignancies by Goodman, Karyn A., M.D, Wiegner, Ellen A., M.D, Maturen, Katherine E., M.D, Zhang, Zhigang, Ph.D, Mo, Qianxing, Ph.D, Yang, George, M.D, Gibbs, Iris C., M.D, Fisher, George A., M.D., Ph.D, Koong, Albert C., M.D., Ph.D

“…Purpose We performed a Phase I dose-escalation study to explore the feasibility and safety of treating primary and metastatic liver tumors with single-fraction…”
Get full text

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers by Sikic, Branimir I, Lakhani, Nehal, Patnaik, Amita, Shah, Sumit A, Chandana, Sreenivasa R, Rasco, Drew, Colevas, A Dimitrios, O'Rourke, Timothy, Narayanan, Sujata, Papadopoulos, Kyriakos, Fisher, George A, Villalobos, Victor, Prohaska, Susan S, Howard, Maureen, Beeram, Muralidhar, Chao, Mark P, Agoram, Balaji, Chen, James Y, Huang, Jie, Axt, Matthew, Liu, Jie, Volkmer, Jens-Peter, Majeti, Ravindra, Weissman, Irving L, Takimoto, Chris H, Supan, Dana, Wakelee, Heather A, Aoki, Rhonda, Pegram, Mark D, Padda, Sukhmani K

“…To evaluate the safety, pharmacokinetics, and pharmacodynamics of Hu5F9-G4 (5F9), a humanized IgG4 antibody that targets CD47 to enable phagocytosis. Adult…”
Get full text

A Data-driven Magnetohydrodynamic Simulation of the 2011 February 15 Coronal Mass Ejection from Active Region NOAA 11158 by Fan, Yuhong, Kazachenko, Maria D., Afanasyev, Andrey N., Fisher, George H.

“…Abstract We present a boundary data-driven magnetohydrodynamic (MHD) simulation of the 2011 February 15 coronal mass ejection (CME) event of Active Region NOAA…”
Get full text

Intraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging by Tummers, Willemieke S., Miller, Sarah E., Teraphongphom, Nutte T., Gomez, Adam, Steinberg, Idan, Huland, David M., Hong, Steve, Kothapalli, Sri-Rajasekhar, Hasan, Alifia, Ertsey, Robert, Bonsing, Bert A., Vahrmeijer, Alexander L., Swijnenburg, Rutger-Jan, Longacre, Teri A., Fisher, George A., Gambhir, Sanjiv S., Poultsides, George A., Rosenthal, Eben L.

“…Background Operative management of pancreatic ductal adenocarcinoma (PDAC) is complicated by several key decisions during the procedure. Identification of…”
Get full text

Natural killer cell and stroma abundance are independently prognostic and predict gastric cancer chemotherapy benefit by Li, Bailiang, Jiang, Yuming, Li, Guoxin, Fisher, Jr, George A, Li, Ruijiang

“…BACKGROUNDSpecific features of the tumor microenvironment (TME) may provide useful prognostic information. We conducted a systematic investigation of the…”
Get full text

Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma by Herman, Joseph M., Chang, Daniel T., Goodman, Karyn A., Dholakia, Avani S., Raman, Siva P., Hacker‐Prietz, Amy, Iacobuzio‐Donahue, Christine A., Griffith, Mary E., Pawlik, Timothy M., Pai, Jonathan S., O'Reilly, Eileen, Fisher, George A., Wild, Aaron T., Rosati, Lauren M., Zheng, Lei, Wolfgang, Christopher L., Laheru, Daniel A., Columbo, Laurie A., Sugar, Elizabeth A., Koong, Albert C.

“…BACKGROUND This phase 2 multi‐institutional study was designed to determine whether gemcitabine (GEM) with fractionated stereotactic body radiotherapy (SBRT)…”
Get full text

A COMPREHENSIVE METHOD OF ESTIMATING ELECTRIC FIELDS FROM VECTOR MAGNETIC FIELD AND DOPPLER MEASUREMENTS by Kazachenko, Maria D, Fisher, George H, Welsch, Brian T

“…Photospheric electric fields, estimated from sequences of vector magnetic field and Doppler measurements, can be used to estimate the flux of magnetic energy…”
Get full text

Single-Fraction Stereotactic Body Radiation Therapy and Sequential Gemcitabine for the Treatment of Locally Advanced Pancreatic Cancer by Schellenberg, Devin, M.D, Kim, Jeff, B.S, Christman-Skieller, Claudia, B.A, Chun, Carlene L., B.S., Ph.D, Columbo, Laurie Ann, R.N, Ford, James M., M.D, Fisher, George A., M.D., Ph.D, Kunz, Pamela L., M.D, Van Dam, Jacques, M.D., Ph.D, Quon, Andrew, M.D, Desser, Terry S., M.D, Norton, Jeffrey, M.D, Hsu, Annie, Ph.D, Maxim, Peter G., Ph.D, Xing, Lei, Ph.D, Goodman, Karyn A., M.D, Chang, Daniel T., M.D, Koong, Albert C., M.D., Ph.D

“…Purpose This Phase II trial evaluated the toxicity, local control, and overall survival in patients treated with sequential gemcitabine and linear…”
Get full text

Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211) by Kunz, Pamela L, Graham, Noah T, Catalano, Paul J, Nimeiri, Halla S, Fisher, George A, Longacre, Teri A, Suarez, Carlos J, Martin, Brock A, Yao, James C, Kulke, Matthew H, Hendifar, Andrew E, Shanks, James C, Shah, Manisha H, Zalupski, Mark M, Schmulbach, Edmond L, Reidy-Lagunes, Diane L, Strosberg, Jonathan R, O'Dwyer, Peter J, Benson, 3rd, Al B

“…Patients with advanced pancreatic neuroendocrine tumors (NETs) have few treatment options that yield objective responses. Retrospective and small prospective…”
Get full text

Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial by Stockton, Shannon, Catalano, Paul, Cohen, Steven J, Burtness, Barbara A, Mitchell, Edith P, Dotan, Efrat, Lubner, Sam J, Kumar, Pankaj, Mulcahy, Mary F, Fisher, George A, Crandall, Theodore L, Benson, Al

“…Abstract Background Patients with advanced esophageal cancer carry poor prognoses; limited data exist to guide second-line therapy in the metastatic setting…”
Get full text

Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer by Tsujikawa, Takahiro, Crocenzi, Todd, Durham, Jennifer N, Sugar, Elizabeth A, Wu, Annie A, Onners, Beth, Nauroth, Julie M, Anders, Robert A, Fertig, Elana J, Laheru, Daniel A, Reiss, Kim, Vonderheide, Robert H, Ko, Andrew H, Tempero, Margaret A, Fisher, George A, Considine, Michael, Danilova, Ludmila, Brockstedt, Dirk G, Coussens, Lisa M, Jaffee, Elizabeth M, Le, Dung T

“…Two studies in previously treated metastatic pancreatic cancer have been completed combining GVAX pancreas vaccine (GM-CSF-secreting allogeneic pancreatic…”
Get full text

EVALUATION OF LANREOTIDE DEPOT/AUTOGEL EFFICACY AND SAFETY AS A CARCINOID SYNDROME TREATMENT (ELECT): A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL by Vinik, Aaron I, Wolin, Edward M, Liyanage, Nilani, Gomez-Panzani, Edda, Fisher, George A

“…To evaluate the efficacy and safety of lanreotide depot/autogel 120 mg for the control of carcinoid syndrome (CS) symptoms in patients with neuroendocrine…”
Get more information

Single- versus Multifraction Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma: Outcomes and Toxicity by Pollom, Erqi L., MD, Alagappan, Muthuraman, BS, von Eyben, Rie, MS, Kunz, Pamela L., MD, Fisher, George A., MD, Ford, James A., MD, Poultsides, George A., MD, Visser, Brendan C., MD, Norton, Jeffrey A., MD, Kamaya, Aya, MD, Cox, Veronica L., MD, Columbo, Laurie A., RN, Koong, Albert C., MD, PhD, Chang, Daniel T., MD

“…Purpose We report updated outcomes of single- versus multifraction stereotactic body radiation therapy (SBRT) for unresectable pancreatic adenocarcinoma…”
Get full text

Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas by Chang, Daniel T., Schellenberg, Devin, Shen, John, Kim, Jeff, Goodman, Karyn A., Fisher, George A., Ford, James M., Desser, Terry, Quon, Andrew, Koong, Albert C.

“…BACKGROUND: The authors report on the local control and toxicity of stereotactic body radiotherapy (SBRT) for patients with unresectable pancreatic…”
Get full text

A Phase I Trial of the ABCB1 Inhibitor, Oral Valspodar, in Combination With Paclitaxel in Patients With Advanced Solid Tumors by Fracasso, Paula M., Fisher, George A., Goodner, Sherry A., Beumer, Jan H., Egorin, Merrill J., Fears, Carole L., Wildi, Jonathan D., Jones, Gary J., Pearce, Tillman E., Sikic, Branimir I.

“…Multidrug resistance mediated by P-glycoprotein is a potential obstacle to cancer treatment. This phase 1 trial determined the safety of paclitaxel with…”
Get full text

Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer by Hege, Kristen M, Bergsland, Emily K, Fisher, George A, Nemunaitis, John J, Warren, Robert S, McArthur, James G, Lin, Andy A, Schlom, Jeffrey, June, Carl H, Sherwin, Stephen A

“…T cells engineered to express chimeric antigen receptors (CARs) have established efficacy in the treatment of B-cell malignancies, but their relevance in solid…”
Get full text

Gemcitabine Chemotherapy and Single-Fraction Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer by Schellenberg, Devin, M.D, Goodman, Karyn A., M.D, Lee, Florence, B.S, Chang, Stephanie, B.A, Kuo, Timothy, M.D, Ford, James M., M.D., Ph.D, Fisher, George A., M.D., Ph.D, Quon, Andrew, M.D, Desser, Terry S., M.D, Norton, Jeffrey, M.D, Greco, Ralph, M.D, Yang, George P., M.D., Ph.D, Koong, Albert C., M.D., Ph.D

“…Purpose Fractionated radiotherapy and chemotherapy for locally advanced pancreatic cancer achieves only modest local control. This prospective trial evaluated…”
Get full text

Long-Term Survivors of Gastric Cancer: A California Population-Based Study by KUNZ, Pamela L, GUBENS, Matthew, FISHER, George A, FORD, James M, LICHTENSZTAJN, Daphne Y, CLARKE, Christina A

“…In the United States, gastric cancer is rapidly fatal with a 25% 5-year survival. Of the few patients who survive, little is known about their demographic,…”
Get full text